DBV Technologies (DBVT) Operating Expenses (2014 - 2026)
DBV Technologies (DBVT) reported Operating Expenses of $48.8 million for Q1 2026, up 78.1% year-over-year from $27.4 million in Q1 2025, and up 6.8% on a QoQ basis from $45.7 million in Q4 2025.
DBV Technologies (DBVT) has 12 years of Operating Expenses data on file, last reported at $48.8 million in Q1 2026.
- Quarterly Operating Expenses rose 78.1% year-over-year to $48.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $174.1 million (up 47.34% YoY) and the FY2025 annual result came in at $152.7 million, up 26.46% from the prior year.
- Operating Expenses rose to $48.8 million in Q1 2026 per DBVT's latest filing, from $45.7 million in the prior quarter.
- Across five years, Operating Expenses topped out at $48.8 million in Q1 2026 and bottomed at $19.3 million in Q1 2022.
- The 5-year median for Operating Expenses is $27.4 million (2025), against an average of $30.3 million.
- The widest annual swing landed in 2022, when Operating Expenses jumped 123.71%; it then tumbled 43.36% in 2023.
- Tracing DBVT's Operating Expenses over 5 years: stood at $36.7 million in 2022, then plunged by 43.36% to $20.8 million in 2023, then gained by 17.2% to $24.4 million in 2024, then jumped by 87.49% to $45.7 million in 2025, then gained by 6.8% to $48.8 million in 2026.
- Per Business Quant, the three latest DBVT Operating Expenses figures stand at $48.8 million (Q1 2026), $45.7 million (Q4 2025), and $37.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.33 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -138.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.85 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.96 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 898.54 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | 48.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.80 Mn |
| Dec 31, 2025 | 45.70 Mn |
| Sep 30, 2025 | 37.05 Mn |
| Jun 30, 2025 | 42.58 Mn |
| Mar 31, 2025 | 27.40 Mn |
| Dec 31, 2024 | 24.37 Mn |
| Sep 30, 2024 | 31.40 Mn |
| Jun 30, 2024 | 35.00 Mn |
| Mar 31, 2024 | 29.96 Mn |
| Dec 31, 2023 | 20.80 Mn |
| Sep 30, 2023 | 20.64 Mn |
| Jun 30, 2023 | 27.36 Mn |
| Mar 31, 2023 | 23.36 Mn |
| Dec 31, 2022 | 36.71 Mn |
| Sep 30, 2022 | 20.09 Mn |
| Jun 30, 2022 | 25.35 Mn |
| Mar 31, 2022 | 19.32 Mn |
| Dec 31, 2021 | 16.41 Mn |
| Sep 30, 2021 | 25.69 Mn |
| Jun 30, 2021 | 29.65 Mn |
| Mar 31, 2021 | 32.58 Mn |
| Dec 31, 2020 | 38.95 Mn |
| Sep 30, 2020 | 33.92 Mn |
| Jun 30, 2020 | 51.31 Mn |
| Mar 31, 2020 | 45.94 Mn |
| Sep 30, 2019 | -38.23 Mn |
| Dec 31, 2018 | -60.48 Mn |
| Sep 30, 2018 | -54.60 Mn |
| Jun 30, 2016 | -61.16 Mn |
| Dec 31, 2015 | -6.02 Mn |
| Jun 30, 2015 | -19.99 Mn |
| Dec 31, 2014 | -5.22 Mn |
| Jun 30, 2014 | -20.22 Mn |